Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid- stimulating hormone, and prolactin regulation

Journal of Clinical Investigation

Volumn 99, Issue 4, 1997, Pages 789-798

  Shimon, Ilan ^a   Taylor, John E ^b   Dong, Jesse Z ^b   Bitonte, Robert A ^c   Kim, Sun ^b   Morgan, Barry ^b   Coy, David H ^d   Culler, Michael D ^b   Melmed, Shlomo ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Biomeasure Inc   (United States)

^c Eve Surgical Center   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

fetal pituitary; growth hormone; prolactin; somatostatin receptor; thyroid stimulating hormone

Indexed keywords

GROWTH HORMONE; PROLACTIN; PROTIRELIN; RECEPTOR SUBTYPE; SOMATOSTATIN RECEPTOR;

ARTICLE; CONTROLLED STUDY; FETUS CELL; GROWTH HORMONE RELEASE; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; HYPOPHYSIS CELL; PRIORITY JOURNAL; PROLACTIN RELEASE; RECEPTOR AFFINITY;

EID: 0031028364     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119225     Document Type: Article

References (62)

1. Brazeau, P., W. Vale, R. Burgus, N. Ling, J. Rivier, and R. Guillemin. 1972. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science (Wash. DC). 129:77-79.
2. Reichlin, S. 1983. Somatostatin. N. Engl. J. Med. 309:1459-1501.
3. Lamberts, S.W.J. 1988. The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. Endocr. Rev. 9:417-436.
4. Lamberts, S.W.J., E.P. Krenning, and J.C. Reubi. 1991. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr. Rev. 12:450-482.
5. Mandarino, L., D. Stenner, W. Blanchard, S. Nissen, J. Gerish, N. Ling, P. Brazeau, P. Bohlen, F. Esch, and R. Guillemin. 1981. Selective effects of somatostatin-14, -25, and -28 on in vitro insulin and glucagon secretion. Nature (Lond.). 291:76-77.
6. Schettini, G. 1991. Brain somatostatin: receptor-coupled transducing mechanisms and role in cognitive functions. Pharmacol. Res. 23:213-215.
7. Yamada, Y., S.R. Post, K. Wang, H. Medical, S. Tager, G.I. Bell, and S. Seino. 1992. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc. Natl. Acad. Sci. USA. 89:251-255.
8. Yasuda, K., S. Rens-Domiano, C.D. Breder, S.F. Law, C.B. Saper, T. Reisine, and G.I. Bell. 1992. Cloning of a novel somatostatin receptor SSTR3, that is coupled to adenylyl cyclase. J. Biol. Chem. 267:20422-20428.
9. Yamada, Y., T. Reisine, S.F. Law, Y. Ihara, A. Kubota, S. Kagimoto, M. Seino, Y. Seino, G.I. Bell, and S. Seino. 1992. Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. Mol. Endocrinol. 6:2136-2142.
10. Bruno, J.F., Y. Xu, J. Song, and M. Berelowitz. 1992. Molecular cloning and functional expression of a novel brain-specific somatostatin receptor. Proc. Natl. Acad. Sci. USA. 89:11151-11155.
11. Roher, L., F. Raulf, C. Bruns, R. Buettner, F. Hofstaedter, and R. Schule. 1993. Cloning and characterization of a fourth human somatostatin receptor. Proc. Natl. Acad. Sci. USA. 90:4196-4200.
12. Xu, Y., H. Song, J.F. Bruno, and M. Berelowitz. 1993. Molecular cloning and sequencing of a human somatostatin receptor, hSSTR4. Biochem. Biophys. Res. Commun. 193:648-652.
13. Yamada, Y., S. Kagimoto, A. Kubota, K. Yasuda, K. Masuda, Y. Someya, Y. Ihara, Q. Li, H. Imura, S. Seino, and Y. Seino. 1993. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and fifth (hSSTR5) human somatostatin receptor subtype. Biochem. Biophys. Res. Commun. 195:844-852.
14. Moyer, D., G.I. Bell, M. Berelowitz, J. Epelbaum, W. Fenink, P. Humphrey, A.M. O'Carroll, Y. Patel, A. Schonbrunn, J. Taylor, and T. Reisine. 1995. Classification and nomenclature of somatostatin receptors. Trends Pharmacol. Sci. 16:86-88.
15. Reisine, T., and G.I. Bell. 1995. Molecular biology of somatostatin receptors. Endocr. Rev. 16:427-442.
16. Patel, Y.C., M. Greenwood, G. Kent, R. Panetta, and C.B. Srikant. 1993. Multiple gene transcripts of the somatostatin receptor SSTR2: tissue selective distribution and cAMP regulation. Biochem. Biophys. Res. Commun. 192:288-294.
17. Rens-Domiano, S., S.F. Law, Y. Yamada, S. Seino, G.I. Bell, and T. Reisine. 1992. Pharmacological properties of two cloned somatostatin receptors. Mol. Pharmacol. 42:28-34.
18. Law, S.F., K. Yasuda, G.I. Bell, and T. Reisine. 1993. Gia3 and Goa selectively associate with the cloned somatostatin receptor subtype SSTR2. J. Biol. Chem. 268:10721-10727.
19. Breder, C.D., Y. Yamada, K. Yasuda, S. Seino, C.B. Saper, and G.I. Bell. 1992. Differential expression of somatostatin receptor subtypes in brain. J. Neurosci. 12:3920-3934.
20. Kaupmann, K., C. Bruns, D. Hoyer, K. Seuwen, and H. Lubbert. 1993. mRNA distribution and second messenger coupling of four somatostatin receptors expressed in brain. FEBS Lett. 331:53-59.
21. Morel, G., P. Leroux, and G. Pelletier. 1985. Ultrastructural autoradiographic localization of somatostatin-28 in the rat pituitary gland. Endocrinology. 116:1615-1620.
22. O'Carroll, A.M., and K. Krempels. 1995. Widespread distribution of somatostatin receptor messenger ribonucleic acids in rat pituitary. Endocrinology. 136:5224-5227.
23. Day, R., W. Dong, R. Panetta. J. Kraicer, M.T. Greenwood, and Y.C. Patel. 1995. Expression of mRNA for somatostatin receptor (sstr) types 2 and 5 in individual rat pituitary cells. A double labeling in situ hybridization analysis. Endocrinology. 136:5232-5235.
24. Panetta, R., and Y.C. Patel. 1995. Expression of mRNA for all five human somatostatin receptors (hSSTRI-5) in pituitary tumors. Life Sci. 56:333-342.
25. Miller, G.M., J.M. Alexander, H.A. Bikkal, L. Katznelson, N.T. Zervas, and A. Klibanski. 1995. Somatostatin receptor subtype gene expression in pituitary adenomas. J. Clin. Endocrinol. Metab. 80:1386-1392.
26. Greenman, Y., and S. Melmed. 1994. Heterogenous expression of two somatostatin receptor subtypes in pituitary tumors. J. Clin. Endocrinol. Metab. 78:398-403.
27. Greenman, Y., and S. Melmed. 1994. Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage. J. Clin. Endocrinol. Metab. 79: 724-729.
28. Raynor, K., W.A. Murphy, D.H. Coy, J.E. Taylor, J.P. Moreau, K. Yasuda, G.I. Bell, and T. Reisine. 1993. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Mol. Pharmacol. 43:838-844.
29. Raynor, K., A.M. O'Carroll, H. Kong, L.C. Mahan, G.I. Bell, and T. Reisine. 1993. Characterization of cloned somatostatin receptors SSTR4 and SSTR5. Mol. Pharmacol. 44:385-392.
30. Patel, Y.C., and C.B. Srikant. 1994. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology. 135:2814-2817.
31. Barinaga, M., G. Yamanoto, G. Rivier, W. Vale, R. Evans, and M.G. Rosenfeld. 1983. Transcriptional regulation of growth hormone gene expression by growth hormone-releasing factor. Nature (Lond.). 306:84-86.
32. Fukata, J., D.J. Diamond, and J.B. Martin. 1985. Effects of rat growth hormone (rGH)-releasing factor and somatostatin on the release and synthesis of rGH in dispersed pituitary cells. Endocrinology. 117:457-467.
33. Yamashita, S., and S. Melmed. 1986. Insulinlike growth factor I regulation of growth hormone gene transcription in primary rat pituitary cells. J. clin. Invest. 79:449-452.
34. DeLean, A., P.J. Munson, and D. Rodbard. 1978. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol. 235:E97-E102.
35. Cohen, C.B., and A.R. Jonsen. 1993. National Advisory Panel on Ethics in reproduction. Policy forum: the future of the fetal tissue bank. Science (Wash. DC). 262:1663-1665.
36. Akita, S., J. Webster, S.G. Ren, H. Takino, J. Said, O. Zand, and S. Melmed. 1995. Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. J. Clin. Invest. 95:1288-1298.
37. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
38. DeNoto, F.M., D.D. Moore, and H.M. Goodman. 1981. Human growth hormone DNA sequence and mRNA structure: possible alternative splicing. Nucleic Acids Res. 9:3719-3730.
39. Hashimoto, K., M. Koga, T. Motomura, S. Kasayama, H. Kouhara, T. Ohnishi, N. Arita, T. Hayakawa, B. Sato, and T. Kishimoto. 1995. Identification of alternatively spliced messenger ribonucleic acid encoding truncated growth hormone-releasing hormone receptor in human pituitary adenomas. J. Clin. Endocrinol. Metab. 80:2933-2939.
40. Ullrich, A., A. Gray, A.W. Tam, T. Yang-Feng, M. Tsubokawa, C. Collins, W. Henzel, T. Le Bon, S. Kathuria, E. Chen, S. Jacobs, U. Francke, J. Ramachandran, and Y. Fujita-Yamaguchi. 1986. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO (Eur. Mol. Biol. Organ.) J. 5:2503-2512.
41. Webb, C.B., J.L. Thominet, and L.A. Frohman. 1983. Ectopic growth hormone releasing factor stimulates growth hormone release from human somatotroph adenoma in vitro. J. Clin. Endocrinol. Metab. 56:417-419.
42. Asa, S.L., K. Kovacs, E. Horvath, N.E. Losinski, F.A. Laszlo, I. Domokos, and W.C. Halliday. 1988. Human fetal adenohypophysis. Electron microscopic and ultrastructural immunocytochemical analysis. Neuroendocrinology. 48:423-431.
43. Asa, S.L., K. Kovacs, and W. Singer. 1991. Human fetal adenohypophysis: morphologic and functional analysis in vitro. Neuroendocrinology. 53:562-572.
44. Rinne, U.K. 1963. Neurosecretory material passing into the hypophysial portal system in the human infundibulum, and its foetal development. Acta Neuroveg. 25:310-324.
45. Ackland, J., S. Ratter, G.L. Bourne, and L.H. Rees. 1983. Characterisation of immunoreactive somatostatin in human fetal hypothamic tissue. Regul. Pept. 5:95-101.
46. Goodyer, C.G., C.L. Branchaud, and Y. Lefebvre. 1993. Effects of growth hormone (GH)-releasing factor and somatostatin on GH secretion from early to midgestation human fetal pituitaries. J. Clin. Endocrinol. Metab. 76:1259-1264.
47. Goodyer, C.G., S. Marcovitz, J. Hardy, Y. Lefebvre, H.J. Guyda, and B.I. Posner. 1987. Effect of insulin-like growth factors on human foetal, adult normal and tumour pituitary function in tissue culture. Acta Endocrinol. 112: 49-57.
48. Reubi, J.C., and A.M. Landolt. 1984. High density of somatostatin receptors in pituitary tumors from acromegalic patients. J. Clin. Endocrinol. Metab. 59:1148-1151.
49. Reubi, J.C., and A.M. Landolt. 1989. The growth hormone responses to Octreotide in acromegaly correlate with adenoma somatostatin receptor status. J. Clin. Endocrinol. Metab. 68:844-850.
50. O'Carroll, A.M., K. Raynor, S.J. Lolait, and T. Reisine. 1994. Characterization of cloned human somatostatin receptor SSTR5. Mol. Pharmacol. 48: 291-298.
51. Moreau, J.P., S. Kim, J.Z. Dong, F. Ignatious, S. Jackson, S.C. Moreau, B.A. Morgan, F. Touraud, J.E. Taylor, B. Tissier et al. 1996. Improved analogs and novel delivery systems for somatostatin octapeptides. Metabolism. 45(Suppl. 1):24-26.
52. Coy, D.H., and J.E. Taylor. 1996. Receptor-specific somatostatin analogs: correlations with biological activity. Metabolism. 45(Suppl. 1):21-23.
53. Ridgway, E.C., A. Klibanski, M.A. Martorana, P. Milbury, J.D. Kieffer, and W.W. Chin. 1983. The effect of somatostatin on the release of thyrotropin and its subunits from bovine anterior pituitary cells in vitro. Endocrinology. 112:1937-1942.
54. Samuels, M.H., P. Henry, and E.C. Ridgway. 1992. Effects of dopamine and somatostatin on pulsatile pituitary glycoprotein secretion. J. Clin. Endocrinol. Metab. 74:217-222.
55. Bertherat, J., T. Brue, A. Enjalbert, G. Gunz, R. Rasolonjanahary, A. Warnet, P. Jaquet, and J. Epelbaum. 1992. Somatostatin receptors on thyrotropin-secreting adenomas: comparison with the inhibitory effects of Octreotide upon in vivo and in vitro hormonal secretions. J. Clin. Endocrinol. Metab. 75: 540-546.
56. Williams, T.C., M. Kelijman, W.C. Crelin, T.R. Downs, and L.A. Frohman. 1988. Differential effects of somatostatin (SRIH) and a SRIH analog, SMS 201-995, on the secretion of growth hormone and thyroid-stimulating hormone in man. J. Clin. Endocrinol. Metab. 66:39-45.
57. Kacsoh, B., B.E. Toth, L.M. Avery, and C.E. Grosvenor. 1993. In vitro control of prolactin (PRL) and growth hormone secretion of neonatal rat pituitary glands: effects of ovine PRL, salmon calcitonin, endothelin-3, angiotensin II, bromocryptine and somatostatin. Life Sci. (Lond.). 52:259-269.
58. Lee, S.C., and S.H. Shin. 1996. Somatostatin does not inhibit prolactin synthesis in normal rat pituitary cells but inhibits prolactin synthesis in estradiol-primed pituitary cells. J. Endocrinol. 148:69-76.
59. Klibanski, A., J.M. Alexander, H.A. Bikkal, D.W. Hsu, B. Swearingen, and N.T. Zervas. 1991. Somatostatin regulation of glycoprotein hormone and free subunit secretion in clinically nonfunctioning and somatotroph adenomas in vitro. J. Clin. Endocrinol. Metab. 73:1248-1255.
60. Katznelson, L., D.S. Oppenheim, J.F. Coughlin, B. Kliman, D.A. Schoenfeld, and A. Klibanski. 1992. Chronic somatostatin analog administration in patients with α-subunit-secreting pituitary tumors. J. Clin. Endocrinol. Metab. 75: 1318-1325.
61. Kubota, A., Y. Yamada, S. Kagimoto, A. Shimatsu, M. Imamura, K. Tsuda, H. Imura, S. Seino, and Y. Seino. 1994. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in the treatment of human endocrine tumors. J. Clin. Invest. 93: 1321-1325.
62. Moldovan, S., A. Atiya, T.E. Adrian, R.M. Kleinman, K. Lloyd, K. Olthoff, D. Imagawa, L. Shelvin, D. Coy, J. Walsh, and F.C. Brunicardi. 1995. Somatostatin inhibits B-cell secretion via a subtype-2 somatostatin receptor in the isolated human pancreas. J. Surg. Res. 59:85-90.